Study Stopped
Terminated due to low enrollment.
Cook Iliac Branch Graft Post-market Registry
1 other identifier
observational
2
1 country
1
Brief Summary
The Cook Iliac Branch Graft Post-market Registry will obtain case reports of physician experience with a CE-marked Cook Iliac Branch Graft to further confirm device safety and performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2010
CompletedFirst Posted
Study publicly available on registry
January 25, 2010
CompletedStudy Start
First participant enrolled
September 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedJune 20, 2013
June 1, 2013
1.9 years
January 22, 2010
June 19, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Internal iliac artery patency
1 year
Aneurysm Exclusion
1 year
Secondary Outcomes (5)
Death
1 year
Conversion
1 year
Rupture
1 year
Success Measures
1 year
Major Complications
1 year
Study Arms (1)
Cook Iliac Branch Graft
Patients implanted with a Cook Iliac Branch Graft
Interventions
Treatment of an aortic, aorto-iliac or iliac aneurysm with a CE-marked Cook Iliac Branch Graft.
Eligibility Criteria
Patients implanted with a Cook Iliac Branch Graft.
You may qualify if:
- CE-Marked Cook Iliac Branch Graft (e.g., Zenith® Branch Endovascular Graft-Iliac Bifurcation, Zenith® Helical Branch Endovascular Graft)
- Registry data are de-identified with respect to patient.
You may not qualify if:
- Patient for whom this device would not normally be considered standard of care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Clinic
Barcelona, 08036, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vincent Riambau, MD, PhD
Hospital Clinic, Barcelona, Spain
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2010
First Posted
January 25, 2010
Study Start
September 1, 2010
Primary Completion
August 1, 2012
Study Completion
August 1, 2012
Last Updated
June 20, 2013
Record last verified: 2013-06